Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313830048> ?p ?o ?g. }
- W4313830048 endingPage "1113" @default.
- W4313830048 startingPage "1102" @default.
- W4313830048 abstract "Abstract Purpose: Approximately 20% of patients with RAS wild-type metastatic colorectal cancer (mCRC) experience objective responses to the anti-EGFR antibody cetuximab, but disease eradication is seldom achieved. The extent of tumor shrinkage correlates with long-term outcome. We aimed to find rational combinations that potentiate cetuximab efficacy by disrupting adaptive dependencies on antiapoptotic molecules (BCL2, BCL-XL, MCL1). Experimental Design: Experiments were conducted in patient-derived xenografts (PDX) and organoids (PDXO). Apoptotic priming was analyzed by BH3 profiling. Proapoptotic and antiapoptotic protein complexes were evaluated by co-immunoprecipitation and electroluminescence sandwich assays. The effect of combination therapies was assessed by caspase activation in PDXOs and by monitoring PDX growth. Results: A population trial in 314 PDX cohorts, established from as many patients, identified 46 models (14.6%) with appreciable (>50% tumor shrinkage) but incomplete response to cetuximab. From these models, 14 PDXOs were derived. Cetuximab primed cells for apoptosis, but only concomitant blockade of BCL-XL precipitated cell death. Mechanistically, exposure to cetuximab induced upregulation of the proapoptotic protein BIM and its sequestration by BCL-XL. Inhibition of BCL-XL resulted in displacement of BIM, which was not buffered by MCL1 and thereby became competent to induce apoptosis. In five PDX models, combination of cetuximab and a selective BCL-XL inhibitor triggered apoptosis and led to more pronounced tumor regressions and longer time to relapse after treatment discontinuation than cetuximab alone. Conclusions: In mCRC tumors that respond to cetuximab, antibody treatment confers a synthetic-lethal dependency on BCL-XL. Targeting this dependency unleashes apoptosis and increases the depth of response to cetuximab." @default.
- W4313830048 created "2023-01-09" @default.
- W4313830048 creator A5013729971 @default.
- W4313830048 creator A5021411537 @default.
- W4313830048 creator A5023997731 @default.
- W4313830048 creator A5024426392 @default.
- W4313830048 creator A5025778865 @default.
- W4313830048 creator A5028066178 @default.
- W4313830048 creator A5031287599 @default.
- W4313830048 creator A5036016726 @default.
- W4313830048 creator A5049302590 @default.
- W4313830048 creator A5049648750 @default.
- W4313830048 creator A5064588430 @default.
- W4313830048 creator A5065261887 @default.
- W4313830048 creator A5079164225 @default.
- W4313830048 date "2023-01-09" @default.
- W4313830048 modified "2023-10-17" @default.
- W4313830048 title "Synthetic Lethal Interaction with BCL-XL Blockade Deepens Response to Cetuximab in Patient-Derived Models of Metastatic Colorectal Cancer" @default.
- W4313830048 cites W1981797550 @default.
- W4313830048 cites W1987443121 @default.
- W4313830048 cites W1990408342 @default.
- W4313830048 cites W2004691500 @default.
- W4313830048 cites W2007847006 @default.
- W4313830048 cites W2009333774 @default.
- W4313830048 cites W2023807845 @default.
- W4313830048 cites W2067275727 @default.
- W4313830048 cites W2085633477 @default.
- W4313830048 cites W2102354469 @default.
- W4313830048 cites W2110525250 @default.
- W4313830048 cites W2112570485 @default.
- W4313830048 cites W2113278680 @default.
- W4313830048 cites W2118571739 @default.
- W4313830048 cites W2144987077 @default.
- W4313830048 cites W2152636515 @default.
- W4313830048 cites W2160852443 @default.
- W4313830048 cites W2165056381 @default.
- W4313830048 cites W2167334545 @default.
- W4313830048 cites W2192121806 @default.
- W4313830048 cites W2272802268 @default.
- W4313830048 cites W2280585894 @default.
- W4313830048 cites W2301454168 @default.
- W4313830048 cites W2316080015 @default.
- W4313830048 cites W2346133077 @default.
- W4313830048 cites W2586712356 @default.
- W4313830048 cites W2617865703 @default.
- W4313830048 cites W2743418290 @default.
- W4313830048 cites W2788735115 @default.
- W4313830048 cites W2891193646 @default.
- W4313830048 cites W2892395616 @default.
- W4313830048 cites W2910046601 @default.
- W4313830048 cites W2953122837 @default.
- W4313830048 cites W2990669650 @default.
- W4313830048 cites W2997329163 @default.
- W4313830048 cites W3012638502 @default.
- W4313830048 cites W3014686038 @default.
- W4313830048 cites W3046925633 @default.
- W4313830048 cites W3048827006 @default.
- W4313830048 cites W3128646645 @default.
- W4313830048 cites W3130224122 @default.
- W4313830048 cites W3164747206 @default.
- W4313830048 cites W3166580483 @default.
- W4313830048 cites W3168590102 @default.
- W4313830048 cites W3207278966 @default.
- W4313830048 cites W4212966936 @default.
- W4313830048 cites W4213345441 @default.
- W4313830048 cites W4214507610 @default.
- W4313830048 cites W4220784600 @default.
- W4313830048 cites W4280545603 @default.
- W4313830048 doi "https://doi.org/10.1158/1078-0432.ccr-22-2550" @default.
- W4313830048 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36622698" @default.
- W4313830048 hasPublicationYear "2023" @default.
- W4313830048 type Work @default.
- W4313830048 citedByCount "1" @default.
- W4313830048 countsByYear W43138300482023 @default.
- W4313830048 crossrefType "journal-article" @default.
- W4313830048 hasAuthorship W4313830048A5013729971 @default.
- W4313830048 hasAuthorship W4313830048A5021411537 @default.
- W4313830048 hasAuthorship W4313830048A5023997731 @default.
- W4313830048 hasAuthorship W4313830048A5024426392 @default.
- W4313830048 hasAuthorship W4313830048A5025778865 @default.
- W4313830048 hasAuthorship W4313830048A5028066178 @default.
- W4313830048 hasAuthorship W4313830048A5031287599 @default.
- W4313830048 hasAuthorship W4313830048A5036016726 @default.
- W4313830048 hasAuthorship W4313830048A5049302590 @default.
- W4313830048 hasAuthorship W4313830048A5049648750 @default.
- W4313830048 hasAuthorship W4313830048A5064588430 @default.
- W4313830048 hasAuthorship W4313830048A5065261887 @default.
- W4313830048 hasAuthorship W4313830048A5079164225 @default.
- W4313830048 hasBestOaLocation W43138300481 @default.
- W4313830048 hasConcept C104317684 @default.
- W4313830048 hasConcept C121608353 @default.
- W4313830048 hasConcept C126322002 @default.
- W4313830048 hasConcept C127561419 @default.
- W4313830048 hasConcept C143998085 @default.
- W4313830048 hasConcept C170493617 @default.
- W4313830048 hasConcept C185592680 @default.
- W4313830048 hasConcept C190283241 @default.
- W4313830048 hasConcept C2776789625 @default.